| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Aug 11, 2021 | Beaurang Pierre Chief Business Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $29.86 | $223,926 | -5.84% |
| Jul 12, 2021 | Jul 12, 2021 | Beaurang Pierre Chief Business Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $23.92 | $179,419 | -5.84% |
| Jun 10, 2021 | Jun 11, 2021 | Beaurang Pierre Chief Business Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $29.37 | $220,248 | -5.84% |
| May 10, 2021 | May 11, 2021 | Beaurang Pierre Chief Business Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $26.49 | $198,644 | -5.84% |
| Apr 12, 2021 | Apr 13, 2021 | Beaurang Pierre Chief Business Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $27.28 | $204,632 | -5.84% |
| Mar 08, 2021 | Mar 09, 2021 | Beaurang Pierre Chief Business Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $37.02 | $277,678 | -6.04% |
| Feb 18, 2021 | Feb 22, 2021 | Beaurang Pierre Chief Business Officer | Sell | Nurix Therapeutics, Inc. | NRIX | $35.49 | $532,352 | -0 |